• Thurs news: Amgen reaps Horizon buyout rewards in Q3. Baxter exits China IV market. Big Pharma earnings. Novo takes steps to end shortages. Roche Alzheimer’s test. See more on our front page


The budget cuts….

anonymous

Guest
Where did the budget cuts really stem from? Did Ethicon US overpromise and under deliver? Was leadership unable to predict the staffing and covid-related drop in procedure volume? If so that seems like a huge miss as I could have told you that a long time ago.
Are all of the operating companies currently dealing with budget restrictions? Pharma, joint recon, trauma, vision, BWI? I’m curious to hear what you have heard if you talk to other JJ employees.
 




Where did the budget cuts really stem from? Did Ethicon US overpromise and under deliver? Was leadership unable to predict the staffing and covid-related drop in procedure volume? If so that seems like a huge miss as I could have told you that a long time ago.
Are all of the operating companies currently dealing with budget restrictions? Pharma, joint recon, trauma, vision, BWI? I’m curious to hear what you have heard if you talk to other JJ employees.

Budget cuts first…..layoffs next
 




Where did the budget cuts really stem from? Did Ethicon US overpromise and under deliver? Was leadership unable to predict the staffing and covid-related drop in procedure volume? If so that seems like a huge miss as I could have told you that a long time ago.
Are all of the operating companies currently dealing with budget restrictions? Pharma, joint recon, trauma, vision, BWI? I’m curious to hear what you have heard if you talk to other JJ employees.

they stemmed from two main things: 1) operations based production costs and 2) Chinas lockdown crush foreign sales. Also a strong dollar hammered our bank roll as we hold a lot accounts receivable in foreign currency.